MedPath
TGA Approval

VABYSMO faricimab 120 mg/mL solution for injection vial (369935)

369935

VABYSMO faricimab 120 mg/mL solution for injection vial

Roche Products Pty Ltd

August 8, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01846-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01845-1

Active Ingredients

faricimab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VABYSMO faricimab 120 mg/mL solution for injection vial (369935) - TGA 批准文号 | MedPath